Dialysis chain NephroPlus engages with bankers for planned $200-250 mn IPO
Backed by Investcorp and Quadria Capital, the company will file its draft papers with the regulator over the next three months, with the listing likely by next year, one person said. The person said the IPO will have a fresh capital raise and an offer by existing investors looking to sell a part of their stake.
'NephroPlus has engaged with ICICI Securities, IIFL Capital Services, Nomura and Ambit Capital to help with the issue," the second person said.
NephroPlus and the investment banks did not respond to Mint's requests for comment on the proposed IPO.
Also Read | Patients saved ₹16,000 crore under Centre's free dialysis scheme
Quadria, a healthcare-focused private equity firm, invested about ₹850 crore for a minority stake in NephroPlus last year through a combination of a primary investment and the purchase of shares from Investcorp, Bessemer Venture Partners, IFC, and IIFL Private Equity.
NephroPlus planned to use the funds raised from Quadria in the IPO for growth in India and overseas. With plans for additional acquisitions, specialised chains such as NephroPlus are expected to gain market share as hospitals increasingly outsource dialysis operations and governments seek to make high-quality dialysis services more accessible.
Demand for dialysis services in the company's target markets is expected to grow at over 11% annually over the next five years, Quadria said when it invested in the company in May 2024.
Founded by Vikram Vuppala and Kamal Shah in 2010, the Hyderabad-based company operates about 450 dialysis centres in 250+ towns and cities across India, the Philippines and Uzbekistan. It serves about 30,000 patients, carrying out 3 million dialysis sessions each year.
Healthcare growth
The company operates in marquee hospitals and standalone clinics, working with leading nephrologists, and also through public-private partnerships in urban and rural areas. Over the past three years, NephroPlus entered the Philippines by acquiring Royal Care Dialysis Centers Inc. and won a public-private partnership bid in Uzbekistan.
NephroPlus' revenue grew to ₹566 crore in FY24 from ₹438 crore a year earlier. It recorded a profit of ₹35 crore from a loss of ₹12 crore in FY23, according to an Entrackr report.
Also Read | Choppy markets take toll on pre-IPO deal talks
The Indian healthcare ecosystem is expected to grow at a CAGR of 16% to $527 billion over the next five years from $250 billion in FY24. The market includes services such as healthcare delivery, diagnostics, medical devices, pharmaceuticals, financing, and health-tech, according to a report by Praxis Global Alliance last year.
Of the $250 billion, healthcare delivery accounts for about 55% (about $135 billion) and is expected to grow at a CAGR of 18% over the next five years. Praxis added that the growth will be primarily driven by changing demographics, increasing urbanisation and health insurance coverage, improving medical tourism, favourable government policies, and rising health awareness and accessibility.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
11 minutes ago
- Hans India
Tesla's entry will strengthen charging infrastructure in Mumbai: CM Fadnavis
Maharashtra Chief Minister Devendra Fadnavis on Tuesday said that Tesla's arrival in India would significantly strengthen Mumbai's electric vehicle (EV) charging infrastructure. His remarks came at the inauguration of Tesla's first 'Experience Centre' in Mumbai. Speaking to the media, Fadnavis noted that Tesla's move to open its Experience Centre marks the American EV giant's formal entry into the Indian market. Beyond this, the company is also working on developing a robust ecosystem for delivery, logistics, and servicing in the region. 'Tesla is setting up four major charging stations in Mumbai, which will help build a large-scale charging infrastructure in the city,' CM Fadnavis added. The Chief Minister also expressed his delight that Tesla has chosen Mumbai for its first showroom in India. He emphasised that Maharashtra is now emerging as a leader in EVs and mobility, thanks to its supportive policies for charging infrastructure and manufacturing incentives, which are drawing global companies to the state. Tesla has launched its journey in India with the introduction of its popular Model Y. The rear-wheel drive (RWD) variant of the Model Y is priced at Rs 59.89 lakh (ex-showroom). The company has also unveiled the long-range RWD variant of the Model Y, priced at Rs 67.89 lakh. Addressing the gathering at the launch event, CM Fadnavis said, 'Mumbai is a symbol of innovation. It represents sustainability. Tesla is not just a car company -- it stands for design, innovation, and sustainability.' Recalling his first encounter with Tesla in the United States, CM Fadnavis said, 'Back in 2015, I had my first ride in a Tesla in the US, and I realised then that this is the kind of vehicle we need for mobility in India.' He added, 'It may have taken you 10 years to get here, but we are thrilled you've finally arrived. I believe the people of Mumbai and India will truly embrace Tesla. Once you begin vehicle deliveries, India will undoubtedly become one of your best markets.'
Hans India
11 minutes ago
- Hans India
DRDO, AIIMS Telangana unveil indigenous, low-cost prosthetic foot
New Delhi: In a first, Indian researchers from the Defence Research and Development Laboratory (DRDL) and AIIMS Bibinagar in Telangana have developed a low-cost prosthetic foot to boost mobility among people with limb loss, the Ministry of Defence said on Tuesday. The first made-in-India cost-effective advanced Carbon Fibre Foot Prosthesis was developed under the Aatmanirbhar Bharat initiative. It will help amputees from lower-income groups get access to good-quality prosthetics, as well as lower the production cost for prosthetics in the country. The new prosthetic foot is biomechanically tested to load up to 125 kg with sufficient safety factors. It also has three variants to cater to patients of different weights. 'This foot is designed with the goal of offering a high-quality and affordable solution accessible to a larger population in need while delivering performance at par with available international models,' the Ministry said. 'It is expected to reduce the cost significantly to as low as less than Rs 20,000 in production in comparison to the current imported similar products that cost around Rs two lakh,' it added. The need for foot prosthetics in India is significant, driven by a high incidence of limb loss due to accidents, medical conditions, and congenital disabilities. Prosthetics offer a crucial means to restore mobility and independence, but affordability and access remain major challenges for many individuals. High-quality prosthetics can be expensive, making them inaccessible to a large segment of the Indian population. Limited access to skilled prosthetists and rehabilitation centers, especially in rural areas, hinders the availability of prosthetic care. The new prosthetic foot is designed for highly dynamic K3-level active users offering high performance at an affordable cost. 'This innovation is expected to significantly improve accessibility to high-quality prosthetics for low-income group amputees in India, reduce dependency on imported technologies, and support broader social and economic inclusion for people with disabilities,' the Ministry said.
Hans India
11 minutes ago
- Hans India
ISMA urges Govt to continue with curbs on ethanol imports
New Delhi: The Indian Sugar Mills Association (ISMA) has urged the government to continue with the restrictions on ethanol imports as the measure has spurred India's petrol blending programme in the drive to green energy and also enabled timely payments to sugarcane farmers. ISMA has, in a letter to Commerce and Industry Minister Piyush Goyal, referred to media reports suggesting the possible consideration of lifting restrictions on ethanol imports for fuel blending, as part of ongoing trade discussions with the US. The latter states that over the last few years, the Government's clear and forward-looking policy direction-anchored in the National Policy on Biofuels which led to placing ethanol imports for fuel under the 'restricted' category, has laid a solid foundation for a self-reliant, domestic ethanol economy. The interest subvention schemes and facilitative regulatory ecosystem have catalysed the establishment and expansion of indigenous ethanol capacities across India, the letter points out. These landmark interventions have achieved multiple national objectives of ensuring timely payments and enhanced incomes for sugarcane farmers, reducing India's dependence on imported crude oil and promoting clean and sustainable biofuels, the letter states. It highlights that the coordinated effort has led to India's ethanol production capacity growing by over 140 per cent since 2018, with investments exceeding Rs 40,000 crore. Ethanol blending has already reached 18.86 per cent and is firmly on track to meet the 20 per cent blending objective ahead of target. This remarkable progress has been made possible due to the Prime Minister's visionary leadership and unwavering commitment to the welfare of India's farmers. This has had a direct and measurable impact on farmers' welfare. By allowing the diversion of sugarcane and surplus grains into ethanol production at administered prices, the government has enabled timely cane payments and improved farm-level incomes across the country, the letter added. The latter states that opening up ethanol imports for blending would pose challenges to the sugar industry as it would affect profitability and may lead to underutilisation of Indian ethanol plants, many of which are still in the early stages of capital recovery.
